Follow
Piotr K. Zakrzewski
Piotr K. Zakrzewski
Department of Cytobiochemistry, Faculty of Biology and Environmental Protection, University of Lodz
Verified email at biol.uni.lodz.pl
Title
Cited by
Cited by
Year
Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH)
M Sałaga, A Mokrowiecka, PK Zakrzewski, A Cygankiewicz, E Leishman, ...
Journal of Crohn's and Colitis 8 (9), 998-1009, 2014
1042014
Transient receptor potential vanilloid 4 blockade protects against experimental colitis in mice: a new strategy for inflammatory bowel diseases treatment?
J Fichna, A Mokrowiecka, AI Cygankiewicz, PK Zakrzewski, ...
Neurogastroenterology & Motility 24 (11), e557-e560, 2012
922012
Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study
J Fichna, JAT Wood, M Papanastasiou, SK Vadivel, P Oprocha, M Sałaga, ...
PLoS One 8 (12), e85073, 2013
612013
Polyphenol extract from evening primrose pomace alleviates experimental colitis after intracolonic and oral administration in mice
M Sałaga, U Lewandowska, D Sosnowska, PK Zakrzewski, ...
Naunyn-Schmiedeberg's archives of pharmacology 387, 1069-1078, 2014
492014
Transient receptor potential vanilloid 4 inhibits mouse colonic motility by activating NO-dependent enteric neurotransmission
J Fichna, DP Poole, N Veldhuis, SJ MacEachern, D Saur, PK Zakrzewski, ...
Journal of Molecular Medicine 93, 1297-1309, 2015
442015
Impaired virus replication and decreased innate immune responses to viral infections in nasal epithelial cells from patients with allergic rhinitis
A Głobińska, M Pawełczyk, A Piechota-Polańczyk, A Olszewska-Ziąber, ...
Clinical & Experimental Immunology 187 (1), 100-112, 2017
382017
Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors
M Sałaga, PR Polepally, PK Zakrzewski, A Cygankiewicz, M Sobczak, ...
Biochemical pharmacology 92 (4), 618-626, 2014
382014
Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases
M Sobczak, A Mokrowiecka, AI Cygankiewicz, PK Zakrzewski, M Sałaga, ...
Journal of Pharmacology and Experimental Therapeutics 348 (3), 401-409, 2014
282014
Mitochondrial O-GlcNAc Transferase Interacts with and Modifies Many Proteins and Its Up-Regulation Affects Mitochondrial Function and Cellular Energy …
P Jóźwiak, P Ciesielski, PK Zakrzewski, K Kozal, J Oracz, G Budryn, ...
Cancers 13 (12), 2956, 2021
242021
Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases
M Sobczak, PK Zakrzewski, AI Cygankiewicz, A Mokrowiecka, C Chen, ...
Pharmacological Reports 66 (5), 741-750, 2014
232014
Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome
M Zielińska, C Chen, A Mokrowiecka, AI Cygankiewicz, PK Zakrzewski, ...
Journal of Pharmacy and Pharmacology 67 (2), 244-254, 2015
212015
TGFβ-pathway is down-regulated in a uterine carcinosarcoma: A case study
A Semczuk, PK Zakrzewski, E Forma, AI Cygankiewicz, ...
Pathology-Research and Practice 209 (11), 740-744, 2013
212013
Canonical TGFβ signaling and its contribution to endometrial cancer development and progression—underestimated target of anticancer strategies
PK Zakrzewski
Journal of clinical medicine 10 (17), 3900, 2021
192021
Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for …
J Fichna, M Sobczak, A Mokrowiecka, AI Cygankiewicz, PK Zakrzewski, ...
Neurogastroenterology & Motility 26 (11), 1539-1550, 2014
192014
Expression of endoglin in primary endometrial cancer
PK Zakrzewski, AI Cygankiewicz, J Mokrosiński, M Nowacka-Zawisza, ...
Oncology 81 (3-4), 243-250, 2011
182011
Dysregulation of betaglycan expression in primary human endometrial carcinomas
PK Zakrzewski, J Mokrosinski, AI Cygankiewicz, A Semczuk, ...
Cancer Investigation 29 (2), 137-144, 2011
122011
Betaglycan Gene (TGFBR3) Polymorphism Is Associated with Increased Risk of Endometrial Cancer
PK Zakrzewski, E Forma, AI Cygankiewicz, M Bryś, K Wójcik-Krowiranda, ...
Journal of Clinical Medicine 9 (10), 3082, 2020
72020
Significance of TGFBR3 allelic loss in the deregulation of TGFβ signaling in primary human endometrial carcinomas
PK Zakrzewski, M Nowacka‑Zawisza, A Semczuk, T Rechberger, ...
Oncology Reports 35 (2), 932-938, 2016
72016
Mitochondrial O-GlcNAc Transferase Interacts with and Modifies Many Proteins and Its Up-Regulation Affects Mitochondrial Function and Cellular Energy Homeostasis. Cancers 2021 …
P Józwiak, P Ciesielski, PK Zakrzewski, K Kozal, J Oracz, G Budryn, ...
O-GlcNAcylation and Cancer, 79, 2021
22021
Zaburzenia kaskady transformujących czynników wzrostu typu β w wybranych patologiach człowieka
P Zakrzewski
Folia Medica Lodziensia 39 (2), 265-292, 2012
22012
The system can't perform the operation now. Try again later.
Articles 1–20